Aims Therapy with an implantable cardioverter defibrillator (ICD) is established for the
prevention of sudden cardiac death (SCD) in high risk patients. We aimed to determine the …

Background Subcutaneous implantable cardioverter-defibrillators provide an alternative to
transvenous defibrillation but require higher shock outputs and offer no antitachycardia …

Introduction: Increasing device implantations, patient comorbidities, and longer life
expectancy contribute to an increased need for lead extraction. Even if transvenous lead …

Over the last 6 decades, cardiovascular implantable electronic devices (CIEDs), including
permanent pacemakers, implantable cardioverterdefibrillators (ICDs), and cardiac …

In the past decade, lead extraction procedure in the management of the leads of cardiac
implantable electrical devices (CIEDs) has increased year by year. The major indication for …

The subcutaneous implantable cardioverter-defibrillator (S-ICD) is unable to deliver
antitachycardia pacing (ATP), bradycardia pacing, and cardiac resynchronization therapy …

Background As the transvenous defibrillator lead is fragile and its failure may cause a life‐
threatening event, reliable insertion techniques are required. While the extrathoracic …

Aims Shock coil interaction in patients with multiple implantable cardioverter defibrillator
(ICD) leads is occasionally observed. We aimed to evaluate the incidence of shock coil …

The approach to cardiac pacemaker implantation has evolved over the past half century.
The early trend from the epicardial approach to the simpler transvenous cutdown led to the …